Edit
Haier Bio-Medical
http://www.haiermedical.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabLast activity: 01.09.2026
Active
Location: China
Employees: 11-50
Founded date: 1998
Investors 1
| Date | Name | Website |
| - | Vivo Capit... | vivocapita... |
Mentions in press and media 9
| Date | Title | Description |
| 01.09.2026 | Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026 | Haier Biomedical Accelerates Its Transformation into an Intelligent Biopharmaceutical Infrastructure Platform at ISPE Singapore 2026 SINGAPORE, Sept. 1, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) showcased a portfolio of automated ... |
| 21.07.2026 | Haier Biomedical Presents Digital Blood Management Platform at ISBT Congress 2026, Advancing Its Transition from Equipment Provider to Full-Process Solution Partner | Driving Digital Transformation in Blood Management for Plasma Collection Centers, Hospitals, and Blood Bank Centers KUALA LUMPUR, Malaysia, July 21, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) participated at the ISBT Congress 2026 ... |
| 25.06.2026 | Haier Biomedical Debuts Innovative Automated Low-Carbon Cold Storage Products at Two Major Global Industry Trade Fairs | From Europe Biobank Week 2026 in Prague to Interphex Week Tokyo 2026, Haier Biomedical continuously strengthens global life sciences market presence through localized innovative products and profound ecosystem partnerships QINGDAO, China, J... |
| 28.05.2026 | Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion | QINGDAO, China, May 28, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) has been named the No. 1 Chinese brand in global life science laboratory equipment sales and No. 1 in overseas sales in the same category, according to 2025 data pu... |
| 20.05.2026 | Haier Biomedical Publishes 2025 Sustainability Report: Committed to Building a Platform for Technology, Industry and Social Responsibility | QINGDAO, China, May 20, 2026 /PRNewswire/ -- Haier Biomedical (688139.SH), a global leader in life sciences and medical solutions, has released its 2025 Sustainability Report, providing a comprehensive overview of the company's measurable p... |
| 30.04.2026 | Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025 | AI-powered growth surges as Haier Biomedical scales from product coverage to premium brand leadership, building a global life science tools and intelligent productivity platform QINGDAO, China, April 30, 2026 /PRNewswire/ -- Haier Biomedica... |
| 11.03.2026 | Haier Biomedical Hosts European Partner Summit in Rome and Advances "In Europe, for Europe" Strategy | ROME, March 11, 2026 /PRNewswire/ -- Haier Biomedical recently convened its European Partner Summit in Rome under the theme "Advancing Together - Sharing the Future of Biomedical Innovation," which brought together 37 regional par... |
| 07.02.2022 | Qingdao Haier Biomedical Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares. | Qingdao Haier Biomedical Co., Ltd. (SHSE:688139) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of shares. The shares will be repurchased at a price of not more than CNY 100 ... |
| 15.04.2021 | Phishing attack ramps up against COVID-19 vaccine supply chain | Image: iStock/gopixa Cybercriminals have been expanding a phishing campaign designed to steal critical information from companies involved with COVID-19 vaccines, security group IBM Security X-Force said on Thursday. In a new report, X-Forc... |